Ionis Pharmaceuticals | IONS - Current Assets


Ionis Pharmaceuticals reported $2.49B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Agios Pharmaceuticals USD 717.67M 117.18M Jun/2026
Alnylam Pharmaceuticals USD 4.62B 400.86M Jun/2026
Arrowhead Research USD 1.67B 168.34M Jun/2026
Astellas Pharma JPY 1.49T 63.68B Jun/2026
BioCryst Pharmaceuticals USD 484.68M 111.06M Jun/2026
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Halozyme Therapeutics USD 1B 177.83M Mar/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 5.82B 45M Jun/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Neurocrine Biosciences USD 1.64B 798.6M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Omeros USD 69.65M 26.53M Jun/2025
OPKO Health USD 535.36M 46.52M Mar/2026
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 41.36B 1.46B Jun/2026
Pharma Mar EUR 280.95M 7.5M Jun/2026
PTC Therapeutics USD 2.62B 363.36M Jun/2026
Qiagen NV USD 1.54B 454.82M Mar/2026
Regeneron Pharmaceuticals USD 18.45B 236.8M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sarepta Therapeutics USD 2.22B 86.05M Jun/2026
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tilray USD 729.32M 28.18M Sep/2025
Ultragenyx Pharmaceutical USD 606M 51M Jun/2026
Vertex Pharmaceuticals USD 12.54B 813.4M Jun/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026